US Stock MarketDetailed Quotes

BOLT Bolt Biotherapeutics

Watchlist
  • 0.761
  • -0.029-3.70%
Close May 28 16:00 ET
29.01MMarket Cap-458P/E (TTM)

About Bolt Biotherapeutics Company

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.

Company Profile

SymbolBOLT
Company NameBolt Biotherapeutics
Listing DateFeb 5, 2021
Issue Price20.00
Founded2015
CEOMr. William P. Quinn
MarketNASDAQ
Employees100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address900 Chesapeake Drive
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94063
Phone1-650-665-9295
Websitehttp://www.boltbio.com

Company Executives

  • Name
  • Position
  • Salary
  • William P. Quinn
  • Director, Chief Financial Officer, President and Chief Executive Officer
  • 912.18K
  • Grant A. Yonehiro
  • Chief Operating Officer
  • 839.50K
  • Sarah Nemec
  • Vice President, Finance and Principal Accounting Officer
  • --
  • Dr. Nicole Onetto, M.D.
  • Independent Director
  • 75.59K
  • Dr. Mahendra Gopaldas Shah, PhD
  • Independent Director
  • 77.09K
  • Kathleen D. Laporte
  • Independent Director
  • 80.59K
  • Dr. James I. Healy, M.D.,PhD
  • Lead Independent Director
  • 78.59K
  • Frank D. Lee
  • Independent Director
  • 74.59K
  • Dr. Richard A. Miller,M.D.
  • Independent Director
  • 79.59K
  • Laura Berner
  • Independent Director
  • 65.59K
  • Brian O'Callaghan
  • Independent Director
  • 83.09K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg